Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(37)
DRUG(25)
PROCEDURE(3)
BEHAVIORAL(1)
Pembrolizumab
3 trials
phase_1phase_2
university-of-california-san-francisco, rahul-aggarwal
Prednisone
3 trials
phase_1phase_1_2phase_3
rahul-aggarwal, alliance-foundation-trials-llc
MRI
3 trials
phase_1phase_1_2
university-of-california-san-francisco, rahul-aggarwal
Apalutamide
3 trials
phase_2phase_3
alliance-foundation-trials-llc, university-of-california-san-francisco +1
Laboratory Biomarker Analysis
2 trials
phase_2
university-of-california-san-francisco
Positron Emission Tomography (PET)
2 trials
early_phase_1phase_1_2
rahul-aggarwal
Tumor Biopsy
2 trials
phase_1
rahul-aggarwal, university-of-california-san-francisco
177Lu-PSMA-617
2 trials
phase_1phase_2
university-of-california-san-francisco

+45 more interventions

53 unique interventions5 categories

Analytics

Trial Phases

Phase 111
Phase 29
Phase 31

Trial Status

Completed10
Recruiting4
Terminated6
Other2

Role Distribution

Principal Investigator20
Other Roles2
PI Rate91%

Activity Timeline

Clinical Trials (20)

NCT07145177Phase 1Recruiting
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
Metastatic Prostate CancerProstate Cancer
PrincipalinvestigatorStart date: 2026-03-16
NCT06942104Phase 1Recruiting
Imaging of Solid Tumors Using 18F-TRX
Castration-Resistant Prostate CarcinomaGlioma, MalignantLocally Advanced Clear Cell Renal Cell Carcinoma+7 more
PrincipalinvestigatorStart date: 2025-07-03
NCT05766371Phase 2Recruiting
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
Castrate Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerProstate Cancer+1 more
PrincipalinvestigatorStart date: 2023-12-15
NCT05888532Phase 1/2Recruiting
64Cu-GRIP B in Patients With Advanced Malignancies
Advanced Solid TumorMetastatic Castration-resistant Prostate CancerProstate Cancer+3 more
PrincipalinvestigatorStart date: 2023-05-25
NCT04926181Phase 2Terminated
Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer
Prostate CancerSmall Cell CarcinomaSmall Cell Neuroendocrine Carcinoma
PrincipalinvestigatorStart date: 2022-03-16
NCT04927663Phase 1Terminated
11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression
Castration-Resistant Prostate CarcinomaMetastatic Castration-resistant Prostate CancerMetastatic Prostate Carcinoma+5 more
PrincipalinvestigatorStart date: 2021-08-10
NCT03503344Phase 2Completed
Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaPSA Progression+1 more
PrincipalinvestigatorStart date: 2019-12-17
NCT03805594Phase 1Completed
177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+4 more
PrincipalinvestigatorStart date: 2019-05-10
NCT03822871Phase 1Completed
A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer
Prostate Cancer
PrincipalinvestigatorStart date: 2019-04-01
NCT03682289Phase 2Active Not Recruiting
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
Clear Cell Renal Cell CarcinomaEndometrial CancerLocally Advanced Malignant Solid Neoplasm+10 more
PrincipalinvestigatorStart date: 2019-01-17

Showing 10 of 20 trials

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Evanthia Evanthia Galanis, MD

Alliance Foundation Trials, LLC.

Related
1 trials

Shared therapeutic areas:

Prostate Cancer

Worked with same sponsors:

Alliance Foundation Trials, LLC.Janssen Research & Development, LLC
Collaborated on 1 trial
Similarity Score14%

Beatrice Langton-Webster, PhD

Cancer Targeted Technology

Related
3 trials

Shared therapeutic areas:

Prostate Cancer

Worked with same sponsors:

Cancer Targeted TechnologyNational Cancer Institute (NCI)+1 more
Collaborated on 1 trial
Similarity Score14%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic MelanomaCarcinoma, Non-Small-Cell LungCancer of Kidney+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Prostate CancerMetastatic Castration-resistant Prostate CancerClear Cell Renal Cell Carcinoma+1 more
Similarity Score2%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Stage IV Prostate CancerMetastatic Prostate CancerProstate Cancer+1 more
Similarity Score2%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Prostate CancerCancer of KidneyClear Cell Renal Cell Carcinoma

Worked with same sponsors:

AstraZenecaNovartis
Similarity Score1%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Solid TumorAdvanced Solid TumorLocally Advanced Pancreatic Cancer
Similarity Score1%

Eric Bellissant, MD, PhD

Rennes University Hospital

Related
26 trials

Shared therapeutic areas:

Metastatic Renal Cell CarcinomaProstate AdenocarcinomaProstate Cancer

Worked with same sponsors:

Merck Sharp & Dohme LLCNovartis
Similarity Score1%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Solid Tumor, AdultCarcinoma, Non-Small-Cell LungSolid Tumor
Similarity Score1%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungProstate Cancer
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (22)

Showing 20 of 22 trials

NCT07145177Phase 1PrincipalInvestigator

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

Metastatic Prostate CancerProstate Cancer
Recruiting
NCT06942104Phase 1PrincipalInvestigator

Imaging of Solid Tumors Using 18F-TRX

Castration-Resistant Prostate CarcinomaGlioma, MalignantLocally Advanced Clear Cell Renal Cell Carcinoma+7 more
Recruiting
NCT05766371Phase 2PrincipalInvestigator

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

Castrate Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerProstate Cancer+1 more
Recruiting
NCT05888532Phase 1/2PrincipalInvestigator

64Cu-GRIP B in Patients With Advanced Malignancies

Advanced Solid TumorMetastatic Castration-resistant Prostate CancerProstate Cancer+3 more
Recruiting
NCT04926181Phase 2PrincipalInvestigator

Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

Prostate CancerSmall Cell CarcinomaSmall Cell Neuroendocrine Carcinoma
Terminated
NCT04927663Phase 1PrincipalInvestigator

11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression

Castration-Resistant Prostate CarcinomaMetastatic Castration-resistant Prostate CancerMetastatic Prostate Carcinoma+5 more
Terminated
NCT03503344Phase 2PrincipalInvestigator

Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer

Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaPSA Progression+1 more
Completed
NCT03805594Phase 1PrincipalInvestigator

177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+4 more
Completed
NCT03822871Phase 1PrincipalInvestigator

A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer

Prostate Cancer
Completed
NCT03682289Phase 2PrincipalInvestigator

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Clear Cell Renal Cell CarcinomaEndometrial CancerLocally Advanced Malignant Solid Neoplasm+10 more
Active Not Recruiting
NCT03590054Phase 1PrincipalInvestigator

Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies

Locally Advanced MelanomaLocally Advanced Solid NeoplasmMetastatic Head and Neck Squamous Cell Carcinoma+18 more
Completed
NCT03009981Phase 3StudyChair

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Prostate Cancer
Completed
NCT02911467Phase 1PrincipalInvestigator

Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate Cancer

Prostate Cancer
Terminated
NCT02913131Phase 1/2PrincipalInvestigator

Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies

Prostate Cancer
Terminated
NCT02450201Early Phase 1PrincipalInvestigator

MRI With C13 Pilot Study Prostate Cancer

Prostate Cancer
Terminated
NCT02735252Not ApplicablePrincipalInvestigator

PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer

Advanced Renal Cell CarcinomaAdvanced Urothelial CarcinomaGenitourinary Cancer+1 more
Active Not Recruiting
NCT02494921Phase 1/2PrincipalInvestigator

LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC

Prostate Cancer
Completed
NCT02391025Early Phase 1PrincipalInvestigator

Gallium-68 Citrate PET Used in Prostate Cancer

Prostatic Neoplasms
Completed
NCT02390011PrincipalInvestigator

Pilot Study of Coil Arrays in Patients With Advanced Solid Tumor Malignancies

Neoplams
Completed
NCT02168062Phase 2PrincipalInvestigator

Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

Prostate Adenocarcinoma
Terminated